Home » Newsletters » BioWorld Science

BioWorld Science

May 24, 2005

View Archived Issues

CytoGenix launches vaccine program using cell-free synthetic DNA production

Aegis and Albany Medical College to develop antiobesity nasal spray

Bayer and Asklepios enter hemophilia gene therapy alliance

Antibodies designated by PDL as lead candidates for cancer therapy

Viragen discontinues development of IEP 11 peptide

ExonHit Therapeutics and Allergan extend strategic alliance

Lilly receives additional E.U. approvals for Strattera

Positive safety profile for DelSite's intranasal vaccine delivery system

Valentis gains rights to Del-1 antibody

Sirtris completes licensing agreement for Washington U HDAC intellectual property

Bionaut Pharmaceuticals and NCI enter cancer research collaboration

Chiron and Enanta agree to develop and commercialize HCV protease inhibitors

AS-6 activates sGC and induces hypotensive effects in rats

Novel positive modulator of alpha7 nAChR described

Solabegron hydrochloride induces bladder relaxation and improves bladder storage mechanism in vivo

Chinese scientists develop and test a novel AT1 receptor antagonist

Novel carbapenems with broad antibacterial activity developed

Sustained-release Melanotan shows promise in preclinical and clinical studies

Clinical evidence of the benefits of bevacizumab in patients with eye disorders

Update on motexafin gadolinium in the treatment of solid tumors

Final phase I results of LEP-ETU in advanced cancer

Myogen evaluates ambrisentan in PAH patients refractory to other ERA therapies

First data on the effects and safety of S-CKD-602 in patients with advanced solid tumors

Nemifitide reported safe and effective for major depression

Eisai receives approval for Aricept Evess orodispersible tablets in U.K.

Fontolizumab reduces Crohn's disease activity in an open-label study

STA-5326 shows potential for Crohn's disease

Novel therapeutics for cardiovascular diseases reported in recent patents

L-000845704: an alphavbeta3 integrin antagonist in trials for osteoporosis

New therapeutics for cancer disclosed in recent patents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...